212 related articles for article (PubMed ID: 9800721)
1. Comments on the note for guidance on bioavailability and bioequivalence in the European Union.
Calvo G
Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():11. PubMed ID: 9800721
[No Abstract] [Full Text] [Related]
2. [Generic drugs, bioavailability, and bioequivalence].
Palma-Aguirre JA
Gac Med Mex; 1998; 134(4):491-4. PubMed ID: 9789395
[No Abstract] [Full Text] [Related]
3. The new European Medicines Agency guideline on the investigation of bioequivalence.
Morais JA; Lobato Mdo R
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):221-5. PubMed ID: 20070293
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and bioequivalence requirements in the European community.
Rauws AG
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():519-32. PubMed ID: 1820933
[TBL] [Abstract][Full Text] [Related]
5. [Bioequivalence studies of pharmaceutical preparations].
Vetchý D; Frýbortová K; Rabisková M; Danecková H
Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963
[TBL] [Abstract][Full Text] [Related]
6. Critical considerations into the new EMA guideline on bioequivalence.
Marzo A; Fontana E
Arzneimittelforschung; 2011; 61(4):207-20. PubMed ID: 21650079
[TBL] [Abstract][Full Text] [Related]
7. Japanese guidance on bioavailability and bioequivalence.
Aoyagi N
Eur J Drug Metab Pharmacokinet; 2000; 25(1):28-31. PubMed ID: 11032086
[TBL] [Abstract][Full Text] [Related]
8. Reassurance about bioequivalence of generic thyroxine.
Feek CM
N Z Med J; 1992 Jan; 105(926):21. PubMed ID: 1549275
[No Abstract] [Full Text] [Related]
9. [Generics: authorization to market and quality guarantees].
De Muylder JA
Rev Med Brux; 2000 Sep; 21(4):A276-8. PubMed ID: 11068480
[TBL] [Abstract][Full Text] [Related]
10. Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins.
Jeske WP; Walenga JM; Hoppensteadt DA; Vandenberg C; Brubaker A; Adiguzel C; Bakhos M; Fareed J
Semin Thromb Hemost; 2008 Feb; 34(1):74-85. PubMed ID: 18393144
[TBL] [Abstract][Full Text] [Related]
11. The end of the beginning?
Nat Biotechnol; 2006 Apr; 24(4):367. PubMed ID: 16601702
[No Abstract] [Full Text] [Related]
12. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.
Quiroz J; Ting N; Wei GC; Burdick RK
Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892
[TBL] [Abstract][Full Text] [Related]
13. Harmonization of bioavailability and bioequivalence requirements.
McGilveray IJ; Ormsby E
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():533-40. PubMed ID: 1820935
[TBL] [Abstract][Full Text] [Related]
14. [Bioavailability and bioequivalence. Studies in healthy volunteers].
Sánchez García P
An R Acad Nac Med (Madr); 1997; 114(3):511-20. PubMed ID: 9549138
[No Abstract] [Full Text] [Related]
15. Generic warfarin: implications for patient care.
Wittkowsky AK
Pharmacotherapy; 1997; 17(4):640-3. PubMed ID: 9250543
[No Abstract] [Full Text] [Related]
16. Generic warfarin: implications for patient care--another view.
Meyer M; Chan K; Bolton S
Pharmacotherapy; 1998; 18(4):884-6; discussion 887-9. PubMed ID: 9692670
[No Abstract] [Full Text] [Related]
17. United States Food and Drug Administration requirements for approval of generic drug products.
Meyer MC
J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence/bioavailability retention samples.
Ransom C
Qual Assur; 1993; 2(1-2):42-3. PubMed ID: 8156218
[No Abstract] [Full Text] [Related]
19. Branded versus generic clozapine: bioavailability comparison and interchangeability issues.
Lam YW; Ereshefsky L; Toney GB; Gonzales C
J Clin Psychiatry; 2001; 62 Suppl 5():18-22; discussion 23-4. PubMed ID: 11305844
[TBL] [Abstract][Full Text] [Related]
20. Are generic and brand name drugs different in terms of quality?
Johns Hopkins Med Lett Health After 50; 2000 Feb; 11(12):8. PubMed ID: 10732507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
